当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:152.18亿  总市值:152.18亿
流通股本:8.82亿   总股本:8.82亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,402,432,066.081,167,024,840.85,379,858,169.924,275,489,879.13
  收到的税费返还222,786,336.9989,282,796.6244,873,943.28208,725,713
  收到其他与经营活动有关的现金107,807,72394,724,379.59224,820,958.39241,355,825.98
  经营活动现金流入小计2,733,026,126.071,351,032,016.995,849,553,071.594,725,571,418.11
  购买商品、接受劳务支付的现金1,238,684,187.75707,719,546.672,451,667,702.352,111,258,852.37
  支付给职工以及为职工支付的现金536,709,554.88313,670,629.19916,088,149.72717,342,209.16
  支付的各项税费192,936,265.0987,891,506.22362,708,151.14303,744,471.69
  支付其他与经营活动有关的现金211,257,448.59105,803,345.43294,842,846.45251,220,845.4
  经营活动现金流出小计2,179,587,456.311,215,085,027.514,025,306,849.663,383,566,378.62
  经营活动产生的现金流量净额553,438,669.76135,946,989.481,824,246,221.931,342,005,039.49
二、投资活动产生的现金流量:
  收回投资收到的现金514,874,773.94340,492,194.9-2,769,230.77
  取得投资收益收到的现金7,721,757.744,085,056.525,024,350.34-
  处置固定资产、无形资产和其他长期资产收回的现金净额568,596.61407,096.615,336,226.743,053,684.76
  处置子公司及其他营业单位收到的现金净额-8,316.54--
  收到的其他与投资活动有关的现金150,000---
  投资活动现金流入小计523,315,128.29344,992,664.5710,360,577.085,822,915.53
  购建固定资产、无形资产和其他长期资产支付的现金231,181,915.44151,629,821.1660,089,439.9434,459,528.27
  投资支付的现金558,000,405.52335,769,405.521,382,371,138.76100,000,000
  投资活动现金流出小计789,182,320.96487,399,226.622,042,460,578.66534,459,528.27
  投资活动产生的现金流量净额-265,867,192.67-142,406,562.05-2,032,100,001.58-528,636,612.74
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,00090,000,000470,000,000470,000,000
  筹资活动现金流入小计90,000,00090,000,000470,000,000470,000,000
  偿还债务支付的现金140,000,00050,000,000815,812,534.16745,848,313.91
  分配股利、利润或偿付利息支付的现金89,206,484.761,230,030455,306,266.56453,456,095.42
  其中:子公司支付给少数股东的股利、利润--4,900,000-
  支付其他与筹资活动有关的现金115,760,678.07-111,593,897.18106,264,596
  筹资活动现金流出小计344,967,162.8351,230,0301,382,712,697.91,305,569,005.33
  筹资活动产生的现金流量净额-254,967,162.8338,769,970-912,712,697.9-835,569,005.33
四、汇率变动对现金及现金等价物的影响-32,905,539.65-18,500,052.73-17,015,588.67-4,113,355
  现金及现金等价物净增加额平衡项目0000.01
五、现金及现金等价物净增加额-301,225.3913,810,344.7-1,137,582,066.22-26,313,933.57
  加:期初现金及现金等价物余额1,456,099,928.741,456,099,928.742,593,681,994.962,593,681,994.96
  期末现金及现金等价物余额1,455,798,703.351,469,910,273.441,456,099,928.742,567,368,061.39
补充资料:
  净利润380,694,022.63-728,543,117.48-
  资产减值准备37,944,608.09-337,761,490.03-
  固定资产和投资性房地产折旧198,362,885.21-370,373,372.02-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧198,362,885.21-370,373,372.02-
  无形资产摊销20,101,627.52-43,988,387.1-
  长期待摊费用摊销2,056,726.72-3,445,908.52-
  处置固定资产、无形资产和其他长期资产的损失2,795,632.28-5,159,651.38-
  固定资产报废损失342,678.92-1,222,476.82-
  财务费用28,722,200.15-23,059,530.07-
  投资损失-10,161,121.37--3,555,802.23-
  递延所得税3,926,863.07--11,557,358.38-
  其中:递延所得税资产减少23,205.46-1,615,712.51-
    递延所得税负债增加3,903,657.61--13,173,070.89-
  存货的减少-34,355,217.91-349,330,400.45-
  经营性应收项目的减少50,221,240.18-162,649,253.74-
  经营性应付项目的增加-144,471,581.69--181,320,332.7-
  其他5,758,690.62-2,198,228.77-
  现金的期末余额1,455,798,703.35-1,456,099,928.74-
  减:现金的期初余额1,456,099,928.74-2,593,681,994.96-
  现金及现金等价物的净增加额-301,225.39--1,137,582,066.22-
公告日期2026-08-042026-04-242026-04-242025-10-16
审计意见(境内)标准无保留意见
TOP↑